CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C20104 | BRD-K55633328 | BRD-K55633328 | -- | -- | -- | Details |
| C20105 | BRD-K55637344 | BRD-K55637344 | -- | -- | -- | Details |
| C20106 | BRD-K55638368 | BRD-K55638368 | -- | -- | -- | Details |
| C20107 | BRD-K55640577 | BRD-K55640577 | -- | -- | -- | Details |
| C20108 | BRD-K55640612 | BRD-K55640612 | -- | -- | -- | Details |
| C20109 | BRD-K55641492 | BRD-K55641492 | -- | -- | -- | Details |
| C20110 | BRD-K55642725 | BRD-K55642725 | -- | -- | -- | Details |
| C20111 | BRD-K55648964 | BRD-K55648964 | -- | -- | -- | Details |
| C20112 | BRD-K55657259 | BRD-K55657259 | -- | -- | -- | Details |
| C20113 | BRD-K55659732 | BRD-K55659732 | -- | -- | -- | Details |
| C20114 | BRD-K55662526 | BRD-K55662526 | -- | -- | -- | Details |
| C20115 | BRD-K55665639 | BRD-K55665639 | -- | -- | -- | Details |
| C20116 | BRD-K55666799 | BRD-K55666799 | -- | -- | -- | Details |
| C20117 | BRD-K55667009 | BRD-K55667009 | -- | -- | -- | Details |
| C20118 | BRD-K55677650 | CO-101244 | GRIN2B | Ionotropic glutamate receptor antagonist | -- | Details |
| C20119 | BRD-K55679243 | BRD-K55679243 | -- | -- | -- | Details |
| C20120 | BRD-K55681368 | BRD-K55681368 | -- | -- | -- | Details |
| C20121 | BRD-K55681488 | BRD-K55681488 | -- | -- | -- | Details |
| C20122 | BRD-K55683015 | SA-89735 | -- | -- | -- | Details |
| C20123 | BRD-K55692246 | BRD-K55692246 | -- | -- | -- | Details |
| C20124 | BRD-K55693448 | BRD-K55693448 | -- | -- | -- | Details |
| C20125 | BRD-K55696337 | topotecan | TOP1 | Topoisomerase inhibitor | -- | Details |
| C20126 | BRD-K55697606 | BRD-K55697606 | -- | -- | -- | Details |
| C20127 | BRD-K55699053 | BRD-K55699053 | -- | -- | -- | Details |
| C20128 | BRD-K55702567 | BRD-K55702567 | -- | -- | -- | Details |
| C20129 | BRD-K55703048 | latrepirdine | HTR6 | Glutamate receptor antagonist | -- | Details |
| C20130 | BRD-K55706946 | BRD-K55706946 | -- | -- | -- | Details |
| C20131 | BRD-K55713064 | BRD-K55713064 | -- | -- | -- | Details |
| C20132 | BRD-K55715339 | BRD-K55715339 | -- | -- | -- | Details |
| C20133 | BRD-K55722623 | BRD-K55722623 | -- | -- | -- | Details |
| C20134 | BRD-K55727377 | BRD-K55727377 | -- | -- | -- | Details |
| C20135 | BRD-K55728478 | BRD-K55728478 | -- | -- | -- | Details |
| C20136 | BRD-K55730324 | BRD-K55730324 | -- | -- | -- | Details |
| C20137 | BRD-K55742134 | BRD-K55742134 | -- | -- | -- | Details |
| C20138 | BRD-K55743249 | BRD-K55743249 | -- | -- | -- | Details |
| C20139 | BRD-K55743364 | BRD-K55743364 | -- | -- | -- | Details |
| C20140 | BRD-K55748775 | SCH-28080 | ATP4A | ATPase inhibitor | -- | Details |
| C20141 | BRD-K55749438 | BRD-K55749438 | -- | -- | -- | Details |
| C20142 | BRD-K55749829 | BRD-K55749829 | -- | -- | -- | Details |
| C20143 | BRD-K55763052 | BRD-K55763052 | -- | -- | -- | Details |
| C20144 | BRD-K55766625 | BRD-K55766625 | -- | -- | -- | Details |
| C20145 | BRD-K55767126 | BRD-K55767126 | -- | -- | -- | Details |
| C20146 | BRD-K55767217 | BRD-K55767217 | -- | -- | -- | Details |
| C20147 | BRD-K55767450 | BRD-K55767450 | -- | -- | -- | Details |
| C20148 | BRD-K55775078 | BRD-K55775078 | -- | -- | -- | Details |
| C20149 | BRD-K55779851 | BRD-K55779851 | -- | -- | -- | Details |
| C20150 | BRD-K55780532 | BRD-K55780532 | -- | -- | -- | Details |
| C20151 | BRD-K55781385 | BMS-927711 | CALCRL; CALCA | Calcitonin antagonist | -- | Details |
| C20152 | BRD-K55792644 | BRD-K55792644 | -- | -- | -- | Details |
| C20153 | BRD-K55793776 | BRD-K55793776 | -- | -- | -- | Details |
| C20154 | BRD-K55795421 | BRD-K55795421 | -- | -- | -- | Details |
| C20155 | BRD-K55800245 | BRD-K55800245 | -- | -- | -- | Details |
| C20156 | BRD-K55806039 | BRD-K55806039 | -- | -- | -- | Details |
| C20157 | BRD-K55808012 | BRD-K55808012 | -- | -- | -- | Details |
| C20158 | BRD-K55809413 | BRD-K55809413 | -- | -- | -- | Details |
| C20159 | BRD-K55813437 | BRD-K55813437 | -- | -- | -- | Details |
| C20160 | BRD-K55814495 | BRD-K55814495 | -- | -- | -- | Details |
| C20161 | BRD-K55815187 | BRD-K55815187 | -- | -- | -- | Details |
| C20162 | BRD-K55816391 | BRD-K55816391 | -- | -- | -- | Details |
| C20163 | BRD-K55819735 | BRD-K55819735 | -- | -- | -- | Details |
| C20164 | BRD-K55827386 | BRD-K55827386 | -- | -- | -- | Details |
| C20165 | BRD-K55835264 | BRD-K55835264 | -- | -- | -- | Details |
| C20166 | BRD-K55836749 | BRD-K55836749 | -- | -- | -- | Details |
| C20167 | BRD-K55841827 | BRD-K55841827 | -- | -- | -- | Details |
| C20168 | BRD-K55844427 | BRD-K55844427 | -- | -- | -- | Details |
| C20169 | BRD-K55847762 | lobenzarit | -- | -- | -- | Details |
| C20170 | BRD-K55851396 | BRD-K55851396 | -- | -- | -- | Details |
| C20171 | BRD-K55852567 | BRD-K55852567 | -- | -- | -- | Details |
| C20172 | BRD-K55853030 | BRD-K55853030 | -- | -- | -- | Details |
| C20173 | BRD-K55853390 | isosorbide-dinitrate | GUCY1A1; GUCY1B1 | Nitric oxide stimulant; Guanylate cyclase stimulant | -- | Details |
| C20174 | BRD-K55854370 | BRD-K55854370 | -- | -- | -- | Details |
| C20175 | BRD-K55855103 | BRD-K55855103 | -- | -- | -- | Details |
| C20176 | BRD-K55857083 | BRD-K55857083 | -- | -- | -- | Details |
| C20177 | BRD-K55860636 | BRD-K55860636 | -- | -- | -- | Details |
| C20178 | BRD-K55864253 | BRD-K55864253 | -- | -- | -- | Details |
| C20179 | BRD-K55867695 | BRD-K55867695 | -- | -- | -- | Details |
| C20180 | BRD-K55869732 | BRD-K55869732 | -- | -- | -- | Details |
| C20181 | BRD-K55875111 | BRD-K55875111 | -- | -- | -- | Details |
| C20182 | BRD-K55877261 | BRD-K55877261 | -- | -- | -- | Details |
| C20183 | BRD-K55878534 | BRD-K55878534 | -- | -- | -- | Details |
| C20184 | BRD-K55880295 | BRD-K55880295 | -- | -- | -- | Details |
| C20185 | BRD-K55883155 | BRD-K55883155 | -- | -- | -- | Details |
| C20186 | BRD-K55884477 | BRD-K55884477 | -- | -- | -- | Details |
| C20187 | BRD-K55889443 | rifapentine | CYP2C8; CYP2C9; CYP3A4 | RNA polymerase inhibitor | -- | Details |
| C20188 | BRD-K55890295 | diaminoquinazoline | -- | -- | -- | Details |
| C20189 | BRD-K55891520 | BRD-K55891520 | -- | -- | -- | Details |
| C20190 | BRD-K55892330 | sorbic-acid | -- | -- | -- | Details |
| C20191 | BRD-K55895855 | BRD-K55895855 | -- | -- | -- | Details |
| C20192 | BRD-K55896279 | BRD-K55896279 | -- | -- | -- | Details |
| C20193 | BRD-K55896440 | BRD-K55896440 | -- | -- | -- | Details |
| C20194 | BRD-K55896799 | BRD-K55896799 | -- | -- | -- | Details |
| C20195 | BRD-K55897144 | BRD-K55897144 | -- | -- | -- | Details |
| C20196 | BRD-K55910052 | BRD-K55910052 | -- | -- | -- | Details |
| C20197 | BRD-K55914420 | BG-1002 | -- | -- | -- | Details |
| C20198 | BRD-K55916310 | BRD-K55916310 | -- | -- | -- | Details |
| C20199 | BRD-K55927371 | BRD-K55927371 | -- | -- | -- | Details |
| C20200 | BRD-K55930204 | phenytoin | SCN1A; SCN2A; SCN5A | Hydantoin antiepileptic | -- | Details |
| C20201 | BRD-K55938002 | VU-0405166-2 | -- | -- | -- | Details |
| C20202 | BRD-K55939029 | BRD-K55939029 | -- | -- | -- | Details |
| C20203 | BRD-K55940699 | BRD-K55940699 | -- | -- | -- | Details |